HMGCR and hearing loss disorder: Supporting a role for the mevalonate pathway, previous work has shown that inhibiting HMG-CoA reductase, which is further upstream in the mevalonate pathway, protected against noise-induced hearing loss in guinea pigs and mice (Park et al., 2012; Richter et al., 2018).